DR. MARK STEPHEN BARON M.D.
Prescription History 1194743708
Psychiatry & Neurology - Neurology in Richmond, VA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. MARK STEPHEN BARON M.D., an active Neurology specialist practicing in Richmond, VA. Our medical registry currently tracks 6 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 155 documented patient claims. Among these therapy options, the most frequently utilized medication is Carbidopa-Levodopa, which accounts for 68 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other VA PrescribersVs. VA Avg |
|---|---|---|---|
| Carbidopa-LevodopaCarbidopa/Levodopa | 68 | $66.76 | ≈ Typical |
About Carbidopa-Levodopa: This combination medication is used to treat symptoms of Parkinson's disease or Parkinson-like symptoms (such as shakiness, stiffness, difficulty moving). Show more ▾ Parkinson's disease is thought to be caused by too little of a naturally occurring substance (dopamine) in the brain. Levodopa changes into dopamine in the brain, helping to control movement. Carbidopa prevents the breakdown of levodopa in the bloodstream so more levodopa can enter the brain. Carbidopa can also reduce some of levodopa's side effects such as nausea and vomiting. In 2024, this provider wrote 68 Medicare prescriptions for Carbidopa-Levodopa, about the same volume as the typical Virginia prescriber of this medication (61.5). Medicare paid an average of $66.76 per fill, versus $32.35 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 162.6 30-Day Fills standardized to 30-day supplies 4,856 Days of Medication total across all patients in 2024 | |||
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 25 | $84.61 | ▼ Less than typical |
About Carbidopa-Levodopa Er: This combination medication is used to treat symptoms of Parkinson's disease or Parkinson-like symptoms (such as shakiness, stiffness, difficulty moving). Show more ▾ Parkinson's disease is thought to be caused by too little of a naturally occurring substance (dopamine) in the brain. Levodopa changes into dopamine in the brain, helping to control movement. Carbidopa prevents the breakdown of levodopa in the bloodstream so more levodopa can enter the brain. Carbidopa can also reduce some of levodopa's side effects such as nausea and vomiting. In 2024, this provider wrote 25 Medicare prescriptions for Carbidopa-Levodopa Er, about 68% of the volume of the typical Virginia prescriber of this medication (36.9). Medicare paid an average of $84.61 per fill, versus $55.47 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 48.2 30-Day Fills standardized to 30-day supplies 1,446 Days of Medication total across all patients in 2024 | |||
| RytaryCarbidopa/Levodopa | 18 | $528.70▼ below VA avg | ▼ Less than typical |
About Rytary: This medication is used to treat the symptoms of Parkinson's disease (such as shakiness, stiffness, difficulty moving) or Parkinson-like conditions. Show more ▾ Parkinson's disease is thought to be caused by too little of a naturally occurring substance (dopamine) in the brain. Levodopa changes into dopamine in the brain, helping to control movement. Carbidopa prevents the breakdown of levodopa in the bloodstream so more levodopa can enter the brain. Carbidopa can also reduce some of levodopa's side effects such as nausea and vomiting. In 2024, this provider wrote 18 Medicare prescriptions for Rytary, about a third of the volume of the typical Virginia prescriber of this medication (55.3). Medicare paid an average of $528.70 per fill, versus $1,341.93 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 19.7 30-Day Fills standardized to 30-day supplies 235 Days of Medication total across all patients in 2024 | |||
| Primidone | 16 | $29.11 | ▼ Less than typical |
About Primidone: This medication is used alone or with other medications to control seizures. Show more ▾ Controlling and reducing seizures lets you do more of your normal daily activities, reduces your risk of harm when you lose consciousness, and lessens your risk for a possibly life-threatening condition of frequent, repeated seizures. Primidone belongs to a class of drugs known as barbiturate anticonvulsants. It works by controlling the abnormal electrical activity in the brain that occurs during a seizure. A barbiturate derivative that acts as a GABA modulator and anti-epileptic agent. It is partly metabolized to PHENOBARBITAL in the body and owes some of its actions to this metabolite. In 2024, this provider wrote 16 Medicare prescriptions for Primidone, about half the volume of the typical Virginia prescriber of this medication (30.1). Medicare paid an average of $29.11 per fill, versus $21.66 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 24 30-Day Fills standardized to 30-day supplies 720 Days of Medication total across all patients in 2024 | |||
| Topiramate | 15 | $23.66 | ▼ Less than typical |
About Topiramate: Topiramate is used alone or with other medications to prevent and control seizures (epilepsy). Show more ▾ This medication is also used to prevent migraine headaches and decrease how often you get them. Topiramate will not treat a migraine headache once it occurs. If you get a migraine headache, treat it as directed by your doctor (such as by taking pain medication, lying down in a dark room). Topiramate is known as an anticonvulsant or antiepileptic drug. A sulfamate-substituted fructose analog that was originally identified as a hypoglycemic agent. It is used for the treatment of EPILEPSY and MIGRAINE DISORDERS, and may also promote weight loss. In 2024, this provider wrote 15 Medicare prescriptions for Topiramate, about half the volume of the typical Virginia prescriber of this medication (32.1). Medicare paid an average of $23.66 per fill, versus $12.73 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 33 30-Day Fills standardized to 30-day supplies 990 Days of Medication total across all patients in 2024 | |||
| Pramipexole DihydrochloridePramipexole Di-Hcl | 13 | $25.23 | ▼ Less than typical |
About Pramipexole Dihydrochloride: Pramipexole is used alone or with other medications to treat Parkinson's disease. Show more ▾ It can improve your ability to move and decrease shakiness (tremor), stiffness, slowed movement, and unsteadiness. It may also decrease the number of episodes of not being able to move ("on-off syndrome"). This medication is also used to treat a certain medical condition (restless legs syndrome - RLS) that causes an unusual urge to move the legs. Symptoms usually occur at night along with uncomfortable/unpleasant feelings in the legs. This medication can decrease these symptoms and thereby improve sleep. Pramipexole is a dopamine agonist that works by helping to restore the balance of a certain natural substance (dopamine) in the brain. A benzothiazole derivative and dopamine agonist with antioxidant properties that is used in the treatment of PARKINSON DISEASE and RESTLESS LEGS SYNDROME. In 2024, this provider wrote 13 Medicare prescriptions for Pramipexole Dihydrochloride, about half the volume of the typical Virginia prescriber of this medication (24). Medicare paid an average of $25.23 per fill, versus $14.83 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 39 30-Day Fills standardized to 30-day supplies 1,170 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DR. MARK STEPHEN BARON M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Neurology prescribing approach at this Richmond, VA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among VA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
